Sale by Tidmarsh George F of 12000 shares of Revelation Biosciences
REVB Stock | USD 0.41 0.04 8.04% |
About 70% of Revelation Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Revelation Biosciences suggests that many traders are alarmed. The current market sentiment, together with Revelation Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Revelation Biosciences stock news signals to limit their universe of possible portfolio assets.
Revelation |
Filed transaction by Revelation Biosciences In director. General open market or private sale of non-derivative or derivative security
Read at macroaxis.com
Cash Flow Correlation
Revelation Biosciences' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Revelation Biosciences' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Revelation Biosciences Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Revelation Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Revelation Biosciences Fundamental Analysis
We analyze Revelation Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revelation Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revelation Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Revelation Biosciences is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Revelation Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Revelation Biosciences stock to make a market-neutral strategy. Peer analysis of Revelation Biosciences could also be used in its relative valuation, which is a method of valuing Revelation Biosciences by comparing valuation metrics with similar companies.
Peers
Revelation Biosciences Related Equities
ZVSA | ZyVersa Therapeutics | 5.66 | ||||
QNRX | Quoin Pharmaceuticals | 5.48 | ||||
CYTO | Altamira Therapeutics | 1.96 | ||||
SONN | Sonnet Biotherapeutics | 3.03 | ||||
KPRX | Kiora Pharmaceuticals | 3.57 | ||||
PHIO | Phio Pharmaceuticals | 3.91 | ||||
VRAX | Virax Biolabs | 6.08 | ||||
RNAZ | Transcode Therapeutics | 6.63 | ||||
ZURA | Zura Bio | 9.71 |
Complementary Tools for Revelation Stock analysis
When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Transaction History View history of all your transactions and understand their impact on performance |